The Clorox Company (CLX) Boston Global Staples Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Boston Global Staples Conference 2026 summary
23 Sep, 2026CEO succession and leadership transition
CEO succession process is well underway, with a comprehensive search in progress and ongoing focus on strategic priorities.
Leadership remains committed to executing the current strategy during the transition period.
Business performance and strategic initiatives
Fiscal 2026 was marked by volatility and transition, including the completion of a major ERP implementation and the acquisition of GOJO Industries (PURELL).
Entering fiscal 2027 in a stronger position, with sequential improvements and a robust innovation pipeline despite ongoing consumer stress and muted categories.
Portfolio expansion into health and hygiene through the GOJO acquisition is expected to drive growth and synergies.
Category trends and innovation
All categories are impacted by value-conscious consumers, with growth in club and mass channels and trading up or down in sizes.
Pro and international categories are outperforming, and innovation is driving premiumization and consumer willingness to pay for superior products.
Strong innovation plans are in place to reignite category growth, focusing on size, price-pack architecture, and brand superiority.
Latest events from The Clorox Company
- FY27 outlook: double-digit sales growth, higher EPS, and GOJO and ERP integration benefits.CLX
Q4 2026 - ERP stabilization, innovation, and GOJO integration drive growth amid leadership transition.CLX
23rd annual dbAccess Global Consumer Conference - GOJO acquisition closed as Q3 sales stayed flat and margin pressure persisted amid cost headwinds.CLX
Q3 2026 - ERP completion, innovation, and GOJO acquisition drive growth and margin expansion plans.CLX
Citi’s 2026 Global Consumer & Retail Conference 2026 - Q2 FY2026 sales and earnings declined, with major acquisitions and ongoing cost pressures.CLX
Q2 2026 - $2.25B acquisition expands health & hygiene leadership, driving $50M in synergies.CLX
M&A announcement - Net sales fell 19% and gross margin dropped to 41.7% amid ERP transition impacts.CLX
Q1 2026 - FY25 margin and EPS growth driven by ERP shipments, with FY26 headwinds as benefits reverse.CLX
Q4 2025 - Digital transformation and IGNITE strategy accelerate growth, margin expansion, and innovation.CLX
Consumer Analyst Group of New York Conference 2025